Prognostic significance of CD56 and CD117 expression in patients with newly diagnosed multiple myeloma treated with bortezomib-based first-line therapy.
- Author:
Jie SHI
1
;
Kai SUN
;
Zun Min ZHU
;
Ping Chong LEI
;
Zhong Wen LIU
;
Yu Qing CHEN
;
Jian Min GUO
;
Yu Zhu ZANG
;
Jing YANG
;
Yin ZHANG
Author Information
- Publication Type:Journal Article
- MeSH: Bortezomib/therapeutic use*; CD56 Antigen; Humans; Multiple Myeloma; Prognosis; Proto-Oncogene Proteins c-kit
- From: Chinese Journal of Hematology 2019;40(8):693-696
- CountryChina
- Language:Chinese
